Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03670966
Title 211At-BC8-B10 and Donor Stem Cell Transplant in Treating Relapsed or Refractory AML, ALL, or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

BC8-B10 + Cyclophosphamide + Fludarabine

Cyclophosphamide + Filgrastim + Mycophenolate mofetil + Sirolimus + Tacrolimus

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.